MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Prometheus Biosciences, Inc. (NASDAQ: RXDX)
Organization & Developments: Prometheus Biosciences
Parents
Prometheus Biosciences, Inc. (NASDAQ: RXDX)
Children
2020: Prometheus Bio is ready for its close-up shot, following a $130M round to back IBD drugs now headed to the clinic – Endpoints News
2022: Prometheus Biosciences A Buy On Positive Phase 2 Data_seekingalpha.com
2022: Prometheus’ Anti-TL1A Monoclonal Antibody Notches Wins in Colitis, Crohn's
Jumps
Finance & Acquisitions: Prometheus Biosciences
Key People: Prometheus Biosciences